However, we observed a potentially deleterious BRCA2 germline variant (BRCA2 p.S1946P) in two sisters with ovarian cancer (one with clear cell carcinoma and the other with serous carcinoma). This evidence concerns the gene BRCA2 and clear cell adenocarcinoma.